Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1) is a guanine nucleotide exchange factor (GEF) protein encoded by the RALGPS1 gene in humans, located on chromosome 9[3][2]. It contains a Pleckstrin Homology (PH) domain, important for membrane localization, and SH3 binding motifs, which facilitate protein-protein interactions. RALGPS1 specifically activates the small GTPase RALA, thus regulating Ral signaling pathways involved in cytoskeletal organization, cell signaling, and possibly membrane trafficking. The gene is predicted to be expressed in the cytoplasm and plasma membrane. Diseases associated with variants or dysfunction in this protein include mitochondrial complex II deficiency and developmental and epileptic encephalopathy 4[2][9]. There are no approved drugs or known therapeutics that directly target RALGPS1, nor is it a routine clinical biomarker according to current sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1).